DOPPL SA is a spin out of SUN bioscience SA and a leader in engineering industry-standard organoids for disease modeling and personalized medicine. We engage in partnered projects for preclinical drug development by providing relevant, high-quality, and scalable organoid models.

Biotechnology

Life Sciences

Doppl SA

Francesco Piraino

Franck Lesage

Jeroen Van Den Oever

The Engineering and Technical Team at DOPPL SA is responsible for developing and maintaining the software and bioinformatics tools essential for creating and analyzing organoid models. They work collaboratively to enhance data processing and integration capabilities, ensuring the delivery of high-quality, scalable solutions for preclinical drug development. By leveraging their expertise, the team drives innovation and efficiency in the company's personalized medicine initiatives.

Engineering and Technical Team

About

Team members